Bionano Genomics
BNGO
9 hedge funds and large institutions have $2.01M invested in Bionano Genomics in 2019 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 5 closing their positions.
73% more capital invested
Capital invested by funds: $1.16M → $2.01M (+$849K)
0% more funds holding
Funds holding: 9 → 9 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
0.02% less ownership
Funds ownership: 0.03% → 0.01% (-0.02%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$246K |
| 2 |
Two Sigma Investments
New York
|
+$56.1K |
| 3 |
VF
Virtu Financial
New York
|
+$40.3K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$13.4K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$10.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
-$223K |
| 2 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$59K |
| 3 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$58K |
| 4 |
Millennium Management
New York
|
-$20K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SCM
1
Sio Capital Management
New York
| $1.5M | -$223K | -381 | -16% |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $313K | +$246K | +421 | New |
|
|
VF
3
Virtu Financial
New York
| $75K | +$40.3K | +69 | +209% |
|
|
4
Two Sigma Investments
New York
| $71K | +$56.1K | +96 | New |
|
|
5
Northern Trust
Chicago,
Illinois
| $17K | +$13.4K | +23 | New |
|
|
TSS
6
Two Sigma Securities
New York
| $14K | +$10.5K | +18 | New |
|
7
UBS Group
Zurich,
Switzerland
| $12K | +$9.94K | +17 | New |
|
8
BlackRock
New York
| $10K | +$1.75K | +3 | +30% |
|
|
MIM
9
Monashee Investment Management
Boston,
Massachusetts
| – | -$59K | -138 | Closed |
|
|
WVP
10
Worth Venture Partners
Fort Lee,
New Jersey
| – | -$58K | -134 | Closed |
|
|
11
Millennium Management
New York
| – | -$20K | -48 | Closed |
|
|
12
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$5K | -12 | Closed |
|
13
Morgan Stanley
New York
| – | -$585 | -1 | -50% |
|
14
Victory Capital Management
San Antonio,
Texas
| – | -$1K | -1 | Closed |
|
BNGO Hedge Fund Activity: Q4 2019 in Review
9 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q4 2019, worth a combined $2.01M — up 73% from $1.16M a quarter earlier.
Fund positioning in BNGO was balanced in Q4 2019: 5 funds opened new positions, 5 closed out, 2 added to existing stakes and 2 trimmed.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $246K. The largest seller was Sio Capital Management, cutting an estimated $223K.
- 9 institutional investors held Bionano Genomics (BNGO) as of Q4 2019, unchanged from Q3 2019.
- Funds reported $2.01M of Bionano Genomics stock for Q4 2019, up 73% quarter-over-quarter.
- 5 funds opened new Bionano Genomics positions in Q4 2019 and 5 closed out, a net change of 0 holders.
- The largest Bionano Genomics buyer in Q4 2019 was Geode Capital Management, an estimated $246K added.
- The largest Bionano Genomics seller in Q4 2019 was Sio Capital Management, an estimated $223K sold.
Based on aggregated 13F filings for Q4 2019.